-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Streptococcus pneumoniae is a bacterium that can cause many common diseases, from serious diseases such as meningitis, sepsis and pneumonia to more mild and common infections such as sinusitis and otitis media .
infection
Pfizer announced today that the European Medicines Management Agency (EMA) has approved the review of a marketing authorization application (MAA) in its 20-valent pneumococcal conjugate vaccine (20vPnC) of the vaccine is designed to prevent the age of 18 and adults over of Streptococcus pneumoniae pneumonia.
Management prevention
Dr.
More than half of all invasive pneumococcal disease cases are caused by 20 serotypes covered by 20vPnC, including 7 serotypes (8, 10A, 11A, 12F, 15B, 22F, and 33F).
immunity
Original source:
Original source:https://target="_blank" rel="noopener">https:// style="vertical-align: inherit;"> https:// leave a message here